Q1

US PROSPECTS

The Association of Investment Companies (AIC) has warned venture capital trust (VCT) fundraising will halve next year, if the vehicles are not granted an exemption from the FSA's sales ban on unregulated collective investment schemes (UCIS) to ordinary...

Former AXA Framlington Biotechnology fund manager Andy Smith has joined biopharma specialist Mann Bioinvest to launch an income-focused fund in the coming weeks.

Investors still face at least two years of uncertainty before a degree of normality returns to markets, according to Jim Stride, head of AXA IM's £13bn Distribution range.

Janus Capital Group's fixed income team has reduced the credit weighting and high yield exposure across its Core Plus bond strategy.

WEALTH MANAGERS

Opting for either austerity or growth in the UK will not be enough to tackle the real structural problems facing the country, according to a leading economist.

Hedge funds posted their best opening quarter performance since 2006, despite seeing flat returns in March.

Now some of you may call me a hypocrite when you read what I am about to propose. The industry has long been saying that there is regulatory overload in the fund management world.

Top managers spy high yield opportunities as European Central Bank's liquidity injections transform banks' refinancing operations.